FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034621151> ?p ?o ?g. }

• W2034621151 endingPage "e88406" @default.
• W2034621151 startingPage "e88406" @default.
• W2034621151 abstract "Background PCV7 was introduced as universal childhood vaccination in Israel in July 2009 and PCV13 in November 2010. Here we report data on adult invasive pneumococcal disease (IPD), two years post PCV7 implementation and before an expected effect of PCV13. Methods An ongoing nationwide active-surveillance (all 27 laboratories performing blood cultures in Israel), providing all blood & CSF S. pneumoniae isolates from persons >18 y was initiated in July 2009. Capture-recapture method assured reporting of >95% cases. All isolates were serotyped in one central laboratory. IPD outcome and medical history were recorded in 90%. Second year post PCV implementation is compared to the first year. Results During July 2009 to June 2011, 970 IPD cases were reported (annual incidence [/100,000] of 9.17 and 10.16 in the two consecutive years, respectively). Respective case fatality rates (CFRs) were 20% and 19.1%. Incidence of IPD and CFR increased with age and number of comorbidities. Incidence rate was significantly greater during the second winter, 7.79/100,000 vs. 6.14/100,000 in first winter, p = 0.004, with a non-significant decrease during summer months (3.02 to 2.48/100,000). The proportion of IPD cases due to PCV7-serotypes decreased from 27.5% to 13.1% (first to second year) (p<0.001). Yet, non-PCV13-strains increased from 32.7% to 40.2% (p = 0.017). The increase in non-PCV13-strains was highly significant in immunocompromised patients and to a lesser degree in non-immunocompromised at risk or in older patients (>64 y). Among younger/healthier patients serotype 5 was the major increasing serotype. Penicillin and ceftriaxone resistance decreased significantly in the second year. Conclusions While overall annual incidence of IPD did not change, the indirect effect of PCV7 vaccination was evident by the significant decrease in PCV7 serotypes across all age groups. Increase in non-VT13 strains was significant in immunocompromised patients. A longer follow-up is required to appreciate the full effect of infant vaccination on annual IPD." @default.
• W2034621151 created "2016-06-24" @default.
• W2034621151 creator A5003556422 @default.
• W2034621151 creator A5008897230 @default.
• W2034621151 creator A5011830200 @default.
• W2034621151 creator A5033640217 @default.
• W2034621151 creator A5037478137 @default.
• W2034621151 creator A5054900639 @default.
• W2034621151 creator A5083171243 @default.
• W2034621151 creator A5085180990 @default.
• W2034621151 creator A5085626163 @default.
• W2034621151 creator A5086250528 @default.
• W2034621151 date "2014-02-07" @default.
• W2034621151 modified "2023-09-25" @default.
• W2034621151 title "Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel" @default.
• W2034621151 cites W1588977108 @default.
• W2034621151 cites W1984739827 @default.
• W2034621151 cites W2001026274 @default.
• W2034621151 cites W2004466670 @default.
• W2034621151 cites W2010088615 @default.
• W2034621151 cites W2020278497 @default.
• W2034621151 cites W2031921493 @default.
• W2034621151 cites W2040244976 @default.
• W2034621151 cites W2042944880 @default.
• W2034621151 cites W2049737273 @default.
• W2034621151 cites W2049956598 @default.
• W2034621151 cites W2054736535 @default.
• W2034621151 cites W2057288433 @default.
• W2034621151 cites W2063133617 @default.
• W2034621151 cites W2082596529 @default.
• W2034621151 cites W2083112925 @default.
• W2034621151 cites W2086019477 @default.
• W2034621151 cites W2089041217 @default.
• W2034621151 cites W2097362862 @default.
• W2034621151 cites W2098483219 @default.
• W2034621151 cites W2105058231 @default.
• W2034621151 cites W2115938372 @default.
• W2034621151 cites W2119422239 @default.
• W2034621151 cites W2126106976 @default.
• W2034621151 cites W2127846934 @default.
• W2034621151 cites W2130226460 @default.
• W2034621151 cites W2130492588 @default.
• W2034621151 cites W2143225304 @default.
• W2034621151 cites W2143927183 @default.
• W2034621151 cites W2149176649 @default.
• W2034621151 cites W2152555903 @default.
• W2034621151 cites W2154756154 @default.
• W2034621151 cites W2183027487 @default.
• W2034621151 doi "https://doi.org/10.1371/journal.pone.0088406" @default.
• W2034621151 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3917916" @default.
• W2034621151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24516649" @default.
• W2034621151 hasPublicationYear "2014" @default.
• W2034621151 type Work @default.
• W2034621151 sameAs 2034621151 @default.
• W2034621151 citedByCount "11" @default.
• W2034621151 countsByYear W20346211512014 @default.
• W2034621151 countsByYear W20346211512015 @default.
• W2034621151 countsByYear W20346211512016 @default.
• W2034621151 crossrefType "journal-article" @default.
• W2034621151 hasAuthorship W2034621151A5003556422 @default.
• W2034621151 hasAuthorship W2034621151A5008897230 @default.
• W2034621151 hasAuthorship W2034621151A5011830200 @default.
• W2034621151 hasAuthorship W2034621151A5033640217 @default.
• W2034621151 hasAuthorship W2034621151A5037478137 @default.
• W2034621151 hasAuthorship W2034621151A5054900639 @default.
• W2034621151 hasAuthorship W2034621151A5083171243 @default.
• W2034621151 hasAuthorship W2034621151A5085180990 @default.
• W2034621151 hasAuthorship W2034621151A5085626163 @default.
• W2034621151 hasAuthorship W2034621151A5086250528 @default.
• W2034621151 hasBestOaLocation W20346211511 @default.
• W2034621151 hasConcept C10389963 @default.
• W2034621151 hasConcept C107130276 @default.
• W2034621151 hasConcept C120665830 @default.
• W2034621151 hasConcept C121332964 @default.
• W2034621151 hasConcept C126322002 @default.
• W2034621151 hasConcept C187212893 @default.
• W2034621151 hasConcept C187316915 @default.
• W2034621151 hasConcept C203014093 @default.
• W2034621151 hasConcept C22070199 @default.
• W2034621151 hasConcept C2776152631 @default.
• W2034621151 hasConcept C2778866548 @default.
• W2034621151 hasConcept C2781253189 @default.
• W2034621151 hasConcept C3020803494 @default.
• W2034621151 hasConcept C501593827 @default.
• W2034621151 hasConcept C61511704 @default.
• W2034621151 hasConcept C71924100 @default.
• W2034621151 hasConcept C86803240 @default.
• W2034621151 hasConcept C89423630 @default.
• W2034621151 hasConceptScore W2034621151C10389963 @default.
• W2034621151 hasConceptScore W2034621151C107130276 @default.
• W2034621151 hasConceptScore W2034621151C120665830 @default.
• W2034621151 hasConceptScore W2034621151C121332964 @default.
• W2034621151 hasConceptScore W2034621151C126322002 @default.
• W2034621151 hasConceptScore W2034621151C187212893 @default.
• W2034621151 hasConceptScore W2034621151C187316915 @default.
• W2034621151 hasConceptScore W2034621151C203014093 @default.
• W2034621151 hasConceptScore W2034621151C22070199 @default.
• W2034621151 hasConceptScore W2034621151C2776152631 @default.

• next